(Q38965120)

8 September 2017

title

Screening for tuberculosis and HIV in resource-poor countries (English)

1 reference

8 September 2017

1 reference

K M De Cock

1

1 reference

8 September 2017

language of work or name

English

0 references

publication date

1 April 1995

1 reference

8 September 2017

1 reference

8 September 2017

volume

345

1 reference

8 September 2017

issue

8954

1 reference

8 September 2017

page(s)

873-874

1 reference

Risk of tuberculosis in patients with HIV-I and HIV-II infections in Abidjan, Ivory Coast

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990003-9

7 January 2021

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990003-9

7 January 2021

A retrospective cohort study of the risk of tuberculosis among women of childbearing age with HIV infection in Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990003-9

7 January 2021

An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990003-9

7 January 2021

Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990003-9

7 January 2021

The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990003-9

7 January 2021

Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990003-9

7 January 2021

Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990003-9

7 January 2021

Impact of HIV on tuberculosis in Zambia: a cross sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990003-9

7 January 2021

A comparison of clinical features in tuberculosis associated with infection with human immunodeficiency viruses 1 and 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990003-9

7 January 2021

Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990003-9

7 January 2021

Tuberculosis in the UK, 1994: current issues and future trends

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990003-9

7 January 2021

Control of tuberculosis transmission in health care settings. A joint statement of the International Union Against Tuberculosis and Lung Disease (IUATLD) and the Tuberculosis Programme of the World Health Organization (WHO)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2990003-9

7 January 2021

10.1016/S0140-6736(95)90003-9

Identifiers

DOI

1 reference

8 September 2017

1 reference